Cargando…
Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy
The therapeutic efficacy of cisplatin and oxaliplatin depends on the balance between the DNA damage induction and the DNA damage response of tumor cells. Based on clinical evidence, oxaliplatin is administered to cisplatin-unresponsive cancers, but the underlying molecular causes for this tumor spec...
Autores principales: | Slyskova, Jana, Muniesa-Vargas, Alba, da Silva, Israel Tojal, Drummond, Rodrigo, Park, Jiyeong, Häckes, David, Poetsch, Isabella, Ribeiro-Silva, Cristina, Moretton, Amandine, Heffeter, Petra, Schärer, Orlando D, Vermeulen, Wim, Lans, Hannes, Loizou, Joanna I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696645/ http://dx.doi.org/10.1093/narcan/zcad057 |
Ejemplares similares
-
Alkylation of nucleobases by 2-chloro-N,N-diethylethanamine hydrochloride (CDEAH) sensitizes PARP1-deficient tumors
por: Wie, Minwoo, et al.
Publicado: (2023) -
EEPD1 promotes repair of oxidatively-stressed replication forks
por: Jaiswal, Aruna S, et al.
Publicado: (2023) -
APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response
por: Conner, Kayla L, et al.
Publicado: (2020) -
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
por: Dibitetto, Diego, et al.
Publicado: (2020) -
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
por: Armstrong, Chris W D, et al.
Publicado: (2020)